SUMMARY

OncologySTAT Editorial Team

Approximately one-third of women eligible for adjuvant treatment of early-stage breast cancer refuse this treatment. Previous studies have shown that beliefs and attitudes play a large part in such decisions. Patients who have more positive beliefs about the benefits and risks of tamoxifen therapy, for instance, are more likely to adhere to therapy. Other studies have shown that patients’ knowledge, as well as their beliefs and perceptions, influences treatment choice. This study surveyed patients’...